• Gujarat
  • India
  • World
  • Sports
  • Entertainment
  • Education
  • Lifestyle
    • Fashion
    • Recipe
    • Travel
    • Health
  • Others
    • Business
    • Technology
    • Horoscope
  • ગુજરાતી
  • Gujarat
  • India
  • World
  • Sports
  • Entertainment
  • Education
  • Lifestyle
    • Fashion
    • Recipe
    • Travel
    • Health
  • Others
    • Business
    • Technology
    • Horoscope
  • ગુજરાતી
Authors

Powered by

Sun Pharma

Sun Pharma gets USFDA approval for new device to treat skin disease

Sun Pharma gets USFDA approval for new device to treat skin disease

By Connect Gujarat Desk 16 May 2025
Sun Pharma share price declines as it revises bid to buy balance Taro stake Business

Sun Pharma share price declines as it revises bid to buy balance Taro stake

Sun Pharmaceutical Industries share price, having gained 56% in the last six months, declined 1.91% in intraday trades on Tuesday

By Connect Gujarat Desk 12 Dec 2023
Share
Twitter Share Whatsapp LinkedIn
US FDA halts Sun Pharma's trials on dermatological drug Health & Fitness

US FDA halts Sun Pharma's trials on dermatological drug

The company said it would work closely with the US FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next 30 days

By Connect Gujarat Desk 02 May 2023
Share
Twitter Share Whatsapp LinkedIn
Sun Pharma acquires 26.09% stake in Agatsa Software, 27.39% in Remidio Innovative Solutions Business

Sun Pharma acquires 26.09% stake in Agatsa Software, 27.39% in Remidio Innovative Solutions

Meanwhile, Sun Pharmaceutical Industries has reported a consolidated net profit at ₹2,166 crore for Q3 FY23

By Connect Gujarat Desk 19 Feb 2023
Share
Twitter Share Whatsapp LinkedIn
Sensex tanks 870 points as Ukraine crisis continues to roil global markets Business

Sensex tanks 870 points as Ukraine crisis continues to roil global markets

Equity benchmark Sensex crashed about 870 points to slip below the 55,000-level in opening deals on Monday

By Connect Gujarat Desk 28 Feb 2022
Share
Twitter Share Whatsapp LinkedIn
Web Stories
No more pages
Powered by


Subscribe to our Newsletter!




Powered by